Q32 Bio Inc. · NASDAQ:QTTB
BVF PARTNERS L P/IL reported a 9.99% stake in Q32 Bio Inc. (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 16, 2026
BVF PARTNERS L P/IL reported a 9.99% stake in Q32 Bio Inc., 3,043,222 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 3,043,222
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 6.30% | 1,924,671 |
| BVF I GP LLC | 6.30% | 1,924,671 |
| BIOTECHNOLOGY VALUE FUND II LP | 3.10% | 929,003 |
| BVF II GP LLC | 3.10% | 929,003 |
| Biotechnology Value Trading Fund OS LP | 0.50% | 155,156 |
| BVF Partners OS Ltd. | 0.50% | 155,156 |
| BVF GP HOLDINGS LLC | 9.40% | 2,853,674 |
| BVF PARTNERS L P/IL | 9.99% | 3,043,222 |
| BVF INC/IL | 9.99% | 3,043,222 |
| LAMPERT MARK N | 9.99% | 3,043,222 |
Source
Download original · View original at SEC
Related
- Q32 Bio Inc.
- Bvf Partners L P
- Q32 Bio Inc. shareholders
- Schedule 13G · Bvf Partners L P · Jun 4, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Nov 16, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Nov 16, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Nov 16, 2026
- Schedule 13G/A · Opaleye Management Inc. · Nov 6, 2026
- Schedule 13G/A · Boxer Capital Management, LLC · Nov 6, 2026